NEOSPACE trial: Neoadjuvant pembrolizumab-gemcitabine-cisplatin followed by concurrent pembrolizumab-chemoradiation and maintenance pembrolizumab for stage IVA nasopharyngeal cancer (NPC).

Hui, EP; Ma, B; Lim, DWT; Lam, WKJ; Soong, YL; Li, L; Wong, KCW; Lam, D; Mok, F; Tong, M; Poon, DMC; Wong, CH; Mo, F; King, AD; Lo, KW; Chan, JYK; Chan, KCA; Chan, ATC

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索